Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases. Our lead indication is for treatment of Primary Open-Angle Glaucoma. Mannin Research is a research stage biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases using the Tie2 mechanism of act...
Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases. Our lead indication is for treatment of Primary Open-Angle Glaucoma. Mannin Research is a research stage biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases using the Tie2 mechanism of action. Mannin’s Tie2 platform technology addresses a number of vascular disease indications. Mannin is currently developing a small molecule to reduce intra-ocular pressure.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.